NYU Langone Hospital - Long Island | Dialysis and Nephrology

Research site
200 Old Country Road, Mineola, New York, United States of America
Site insights

Top conditions

Pathologic Constriction (2 trials)

Mitral Valve Insufficiency (2 trials)

Diabetes Mellitus (2 trials)

Hypertriglyceridemia (2 trials)

Aortic Valve Stenosis (2 trials)

Top treatments


Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


12 of 20
Status: Active
Trial type: Interventional
Funder type: Industry

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation (Krascendo 170)

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and activity of divarasib combined with other anti-cancer therapies in pa...

Non-Small Cell Lung Cancer
Drug: Pemetrexed
Drug: Divarasib

The main purpose of this study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participa...

Active, not recruiting
Type 1 Diabetes
Drug: Insulin Degludec
Drug: Insulin Efsitora Alfa

The main aims of this study are to test for any side effects from modakafusp alfa in combination therapy and to determine the recommended dose of com...

Active, not recruiting
Multiple Myeloma
Drug: Pomalidomide
Drug: Modakafusp alfa

The purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from ba...

Severe Hypertriglyceridemia
Drug: Olezarsen
Drug: Placebo

The main purpose of this study is to investigate the effect of retatrutide on renal function in participants with overweight or obesity and chronic k...

Overweight or Obesity
Drug: LY3437943
Drug: Placebo
Locations recently updated

The purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.

Sjögren's Syndrome
Drug: Deucravacitinib
Other: Placebo

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation...

Degenerative Mitral Valve Disease
Functional Mitral Regurgitation
Device: Edwards PASCAL System
Device: Abbott Mitraclip System

To assess the safety and tolerability of increasing doses of PF-07104091 and to estimate the Maximum Tolerated Dose (MTD) and/or select the Recommend...

Breast Cancer
Small Cell Lung Cancer
Drug: PF-07104091 monotherapy dose expansion (SCLC)
Drug: PF-07104091 monotherapy dose expansion (ovarian)

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Hea...

Active, not recruiting
Aortic Valve Stenosis
Aortic Stenosis, Calcific
Device: SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA

RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to...

Active, not recruiting
Hypertension, Resistant to Conventional Therapy
Device: Renal Denervation

This study is to understand if the study vaccine (called VLA15) is safe in healthy children.We are looking for children who:are healthyare age 5 thro...

Active, not recruiting
Lyme Disease
Biological: VLA15
Other: Normal Saline

Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.

Mitral Valve Regurgitation
Device: Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)

Trial sponsors

Pfizer logo

Pfizer (4 trials)

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems